Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Redwood City, California, dedicated to creating innovative therapies for rare diseases. Leveraging its proprietary drug development platform, Soleno is focused on addressing significant unmet medical needs through its advanced clinical trials. With a strong emphasis on rare diseases, the company represents a compelling investment opportunity for institutional investors seeking to engage with cutting-edge biopharmaceutical advancements and capitalize on emerging market possibilities. Show more
Location: 100 MARINE PARKWAY, REDWOOD CITY, CA, UNITED STATES, 94065, Redwood City, CA, 94065, USA | Website: https://soleno.life | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
2.071B
52 Wk Range
$37.95 - $90.32
Previous Close
$38.56
Open
$39.88
Volume
2,183,962
Day Range
$39.51 - $42.73
Enterprise Value
1.625B
Cash
246.7M
Avg Qtr Burn
N/A
Insider Ownership
2.00%
Institutional Own.
-
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
VYKAT XR (diazoxide choline) (DCCR) Details Prader-Willi syndrome | Approved Quarterly sales |
